Cargando…
Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022
Autores principales: | Plumb, Ian D., Feldstein, Leora R., Barkley, Eric, Posner, Alexander B., Bregman, Howard S., Hagen, Melissa Briggs, Gerhart, Jacqueline L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020856/ https://www.ncbi.nlm.nih.gov/pubmed/35421077 http://dx.doi.org/10.15585/mmwr.mm7115e2 |
Ejemplares similares
-
Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 — United States, April–September 2022
por: Shah, Melisa M., et al.
Publicado: (2022) -
Paxlovid associated with decreased hospitalization rate among adults with COVID-19 — United States, April–September 2022
por: Shah, Melisa M., et al.
Publicado: (2023) -
Safety monitoring of COVID-19 vaccines: February 26, 2021, To June 4, 2022, Republic of Korea
por: Lee, Yeon-Kyeng, et al.
Publicado: (2023) -
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status
and Previous COVID-19 Diagnosis — California and New York,
May–November 2021
por: León, Tomás M., et al.
Publicado: (2022) -
Disparities in COVID-19 Vaccine Booster Uptake in the USA: December 2021–February 2022
por: Gaffney, Adam, et al.
Publicado: (2022)